Prognostic implications of biopsy with tumour transection for high-risk primary melanoma patients
Authors
von Schuckmann, LAKhosrotehrani, K
Celia, BH
Van der Pols, JC
Malt, M
Smithers, BM
Green, Adèle C
Affiliation
Population Health Department, QIMR Berghofer Medical Research Institute, AustraliaIssue Date
2020
Metadata
Show full item recordCitation
von Schuckmann LA, Khosrotehrani K, Celia BHM, van der Pols JC, Malt M, Smithers BM, et al. Prognostic implications of biopsy with tumour transection for high-risk primary melanoma patients. J Am Acad Dermatol. 2020.Journal
Journal of the American Academy of DermatologyDOI
10.1016/j.jaad.2020.01.067PubMed ID
32032688Additional Links
https://dx.doi.org/10.1016/j.jaad.2020.01.067Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jaad.2020.01.067
Scopus Count
Collections
Related articles
- Clinical and pathologic factors associated with deep transection of biopsies of invasive melanoma.
- Authors: Woodcock JL, Eyre ZW, Stoddard GJ, Callis Duffin K, Bowen AR
- Issue date: 2017 Oct
- The rate of melanoma transection with various biopsy techniques and the influence of tumor transection on patient survival.
- Authors: Mir M, Chan CS, Khan F, Krishnan B, Orengo I, Rosen T
- Issue date: 2013 Mar
- Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
- Authors: Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR
- Issue date: 2010 Mar 15
- Prognostic factors.
- Authors: Rogers GS, Braun SM
- Issue date: 2002 Oct
- Residual melanoma after an excisional biopsy is an independent prognostic factor for local recurrence and overall survival.
- Authors: Hocevar M, Dragonja Z, Pilko G, Gazic B, Zgajnar J
- Issue date: 2014 Oct